Dexcom Inc. Stock
€64.41
Your prediction
Financial data and news for DexCom
sharewise wants to provide you with the best news and tools for DexCom, so we directly link to the best financial data sources.
Financials
News
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company’s
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
With $200, one can afford many lottery tickets, one of which could be a winner. However, the odds of winning meaningful money by playing the lottery are minuscule. Investing in the stock market
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels.
But the stock has been performing poorly this year amid
Is DexCom a Millionaire-Maker Stock?
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps put
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more accessible -- and perfectly sensible -- strategy is to invest
2 Growth Stocks to Buy at a Discount
If you're looking for stocks on sale in the current market, despite the broader gains that major indices have clocked, many companies have responded in different ways. While a stock trading at a
1 Growth Stock Down 43% to Buy Right Now
Attractive investment opportunities can sometimes arise when investors react emotionally to short-term events. Some of these events revolve around the earnings season, when a company releases
RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
When a stock falls over a cliff after earnings, it can put investors into an unnerving situation: Should you average down, or simply get out of the stock entirely? It's not always an easy question
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
July 25 was a difficult day for DexCom (NASDAQ: DXCM) shareholders, with the company's second-quarter earnings release crashing the stock by 40%. To make matters worse, at the moment it's unclear
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested
2 Magnificent Growth Stocks to Buy Right Now
Not all stocks have responded to the bull market in the some way. While many businesses have followed the broader trend of steadily rising, some stocks are trading down considerably and even coming
Why DexCom Stock Is Crashing Today
Shares of DexCom (NASDAQ: DXCM) were crashing 39.9% lower as of 10:20 a.m. ET on Friday. The huge sell-off came after the continuous glucose monitoring (CGM) systems maker announced its
DexCom (DXCM) Q2 2024 Earnings Call Transcript
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Every good thing must come to an end -- and, eventually, the bull market we're experiencing will, too. Long-term investors must prepare for that to happen at some point.
One of the best ways to do
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes
DexCom (DXCM) Q1 2024 Earnings Call Transcript
2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at